Literature DB >> 12759193

Conference on abuse liability assessment of CNS drugs.

Charles R Schuster1, Jack Henningfield.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12759193     DOI: 10.1016/s0376-8716(03)00095-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


× No keyword cloud information.
  8 in total

1.  Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability.

Authors:  Ty A Ridenour; Mildred Maldonado-Molina; Wilson M Compton; Edward L Spitznagel; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2005-04-26       Impact factor: 4.492

Review 2.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

3.  NIH electronic cigarette workshop: developing a research agenda.

Authors:  Kevin M Walton; David B Abrams; William C Bailey; David Clark; Gregory N Connolly; Mirjana V Djordjevic; Thomas E Eissenberg; Michael C Fiore; Maciej L Goniewicz; Lynne Haverkos; Stephen S Hecht; Jack E Henningfield; John R Hughes; Cheryl A Oncken; Lisa Postow; Jed E Rose; Kay L Wanke; Lucie Yang; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2014-10-21       Impact factor: 4.244

4.  Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.

Authors:  Jack E Henningfield; Dorothy K Hatsukami; Mitch Zeller; Ellen Peters
Journal:  Drug Alcohol Depend       Date:  2011-03-03       Impact factor: 4.492

Review 5.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 6.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 7.  Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.

Authors:  Jack E Henningfield; Saul Shiffman; Stuart G Ferguson; Ellen R Gritz
Journal:  Pharmacol Ther       Date:  2009-04-08       Impact factor: 12.310

8.  Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.

Authors:  Mitchell F Stiles; Leanne R Campbell; Donald W Graff; Bobbette A Jones; Reginald V Fant; Jack E Henningfield
Journal:  Psychopharmacology (Berl)       Date:  2017-06-20       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.